Template:Fibromuscular dysplasia: Difference between revisions

Jump to navigation Jump to search
Sara Mehrsefat (talk | contribs)
No edit summary
Anmol Pitliya (talk | contribs)
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 29: Line 29:
!
!
[[Fibromuscular dysplasia historical perspective|Historical Perspective]]
[[Fibromuscular dysplasia historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
!
[[Fibromuscular dysplasia classification|Classification]]
|-  
|-  
!
!
Line 59: Line 65:
!
!
[[Fibromuscular dysplasia risk factors|Risk Factors]]
[[Fibromuscular dysplasia risk factors|Risk Factors]]
|-
!
|- bgcolor="Pink"
!
[[Fibromuscular dysplasia screening|Screening]]
|-  
|-  
!
!
Line 71: Line 83:
!
!
Diagnosis
Diagnosis
|-
!
|- bgcolor="LightSkyBlue"
!
[[Fibromuscular dysplasia diagnostic study of choice|Diagnostic Study of Choice]]
|-  
|-  
!
!
Line 89: Line 107:
!
!
[[Fibromuscular dysplasia laboratory findings|Laboratory Findings]]
[[Fibromuscular dysplasia laboratory findings|Laboratory Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Fibromuscular dysplasia electrocardiogram|Electrocardiorgram]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Fibromuscular dysplasia x ray|X-ray]]
|-  
|-  
!
!
Line 112: Line 142:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Fibromuscular dysplasia ultrasound|Ultrasound]]
[[Fibromuscular dysplasia echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-  
|-  
!
!
Line 178: Line 208:
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
ACC/AHA Guideline Recommendations  
ASA/ACCF/AHA Guideline Recommendations  
|-  
|-  
!
!
Line 184: Line 214:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Patients With Fibromuscular Dysplasia|Fibromuscular Dysplasia]]
[[Patients With Fibromuscular Dysplasia|Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries]]
|-  
|-  
!
!

Latest revision as of 12:57, 25 April 2018